Oscar Health, Inc. (OSCR): A Bull Case Theory

We came crossed a bullish thesis connected Oscar Health, Inc. connected Investment Ideas by Antonio’s Substack by Antonio Linares. In this article, we volition summarize the bulls’ thesis connected OSCR. Oscar Health, Inc.'s stock was trading astatine $17.97 arsenic of November 28th.

Oscar Health, Inc. operates arsenic a healthcare exertion institution successful the United States. OSCR is positioned to payment from a structural displacement successful the U.S. healthcare system, arsenic evidenced by a rising aesculapian nonaccomplishment ratio (MLR) driven by higher mean marketplace morbidity. The summation successful unwellness among ACA members, attributed to a stealth pandemic of spike macromolecule toxicity and Lyme infections, points to a increasing request for innovative healthcare solutions beyond accepted medicine. Despite short-term losses and a 12-point YoY emergence successful MLR, Oscar remains structurally healthy, with Q2 2025 gross reaching $2.9 billion, up 29% YoY, and its subscriber basal increasing 28% to implicit 2 million.

The company’s platform, which simplifies navigation of the security strategy and continues to amended idiosyncratic value, is well-positioned to seizure this increasing demand. Oscar has a past of successfully re-pricing its publication to align with marketplace dynamics, and its excess superior of $577 cardinal provides a cushion to sorb impermanent losses portion preparing for complaint increases successful 2026. Operating leverage gains are evident, with SG&A ratios trending down contempt short-term fluctuations. The banal trades beneath 0.5 times income owed to governmental hazard concerns astir ACA subsidy renewals, which look improbable to materialize, creating important upside potential.

Complementing Oscar’s positioning, Hims is emerging arsenic a person successful precision medicine, offering solutions that code the underlying molecular drivers of chronic illness. Together, these companies item a broader marketplace accidental driven by rising healthcare complexity, structural tailwinds, and increasing request for innovative solutions, presenting a compelling concern lawsuit with important semipermanent upside.

Previously we covered a bullish thesis connected Oscar Health, Inc. (OSCR) by convexititties successful March 2025, which highlighted the company’s heavy discount owed to ACA governmental risk, beardown management, AI-driven exertion stack, and imaginable re-rating arsenic marketplace stock grows. The company's banal terms has appreciated astir by 16.61% since our coverage. The thesis inactive stands arsenic Oscar remains structurally steadfast and operationally resilient. Antonio Linares shares a akin but emphasizes rising aesculapian nonaccomplishment ratios and structural healthcare tailwinds.